Other languages Gelesis Holdings, Inc.

Equities

GLSH.Q

US36850R2040

End-of-day quote OTC Markets Other stock markets 04:30:00 20/03/2024 am IST			5-day change	1st Jan Change
0.0198 ^USD	+19,79,900.00%		-.--%	+1,220.00%

19/04	Bidding Procedure Approved for Gelesis Holdings, Inc.	CI
09/04	Motion for Asset Sale Filed by Gelesis Holdings, Inc.	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Motion for Joint Administration Approved for Gelesis Holdings, Inc.	01/02
Motion for Joint Administration Filed by Gelesis Holdings, Inc.	31/01
Gelesis Holdings Provides Information to Shareholders	31/23/31
Gelesis Holdings, Inc. Filed for Bankruptcy	30/23/30
PureTech Health plc cancelled the acquisition of the remaining 76.7% stake in Gelesis Holdings, Inc. from Pacific Investment Management Company LLC, Hpso Spv Limited, SSD2 LLC, Cms Medical Venture Investment (HK) Limited and others.	12/23/12
Gelesis Holdings, Inc. Appoints Mr. Yishai Zohar as Chief Compliance Officer, Corporate Secretary, Treasurer, Principal Accounting Officer	22/23/22
Gelesis Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	15/23/15
Orgenesis Names Elliot Maltz Chief Financial Officer	13/23/13
Elliot Maltz, Treasurer, Chief Compliance Officer and Corporate Secretary (And Principal Financial and Accounting Officer) of Gelesis Holdings, Inc. Resigns from All Positions, Effective August 15, 2023	13/23/13
Gelesis Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	16/23/16
Gelesis Holdings, Inc. Announces Board Changes	22/23/22
Gelesis Holdings, Inc. Announces Resignation of Dominic Perks as Class I Director	18/23/18
Gelesis Holdings Provides Information to Shareholders	11/23/11
Gelesis Holdings, Inc. Auditor Raises 'Going Concern' Doubt	28/23/28
KLP Enterprises Engages in Discussions with Gelesis Holdings	31/22/31
Top Premarket Decliners	27/22/27
Gelesis Holdings, Inc. Reiterates Earnings Guidance for the Full Year Fiscal Year 2022	14/22/14
Gelesis Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/22/14
Gelesis Holdings Receives Noncompliance Notice From NYSE	07/22/07
Gelesis Holdings, Inc. to Present Data from the Light Up Study with Gelesis' Oral Hydrogel Treatment Gs200 at Obesity Week	02/22/02

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Gelesis Holdings, Inc.

Equities

GLSH.Q

US36850R2040

Other languages

Filters